Jaguar Health ISIN: US47010C4096 Forum: Aktien Thema: Hauptdiskussion

Danke für die News 👍

Jaguar Health Enters Exclusive Crofelemer Distribution and License Agreement with Quadri Pharmaceuticals Store for Multiple Target Indications in Middle East Markets

Oha das sieht ja immer schlimmer aus. 😅Das wird lange dauern bis ich da wieder grün sehe....

Wegen spac eventuell?

Die sind behindert deshalb

Warum schätzen die analysten jaguar auf 10-12€?? Hab ich was verpasst

wow was ist los

Joschmann, jagx hat neue gruppe seit rs

Jetzt steht der Kurs auf €1,850

Was meint ihr..? Geht wieder oder bleiben bei -79%

SAN FRANCISCO, CA / ACCESSWIRE / November 1, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the merger of its Italian subsidiary Napo EU S.p.A. and Dragon SPAC S.p.A. has closed

wattn scheiss kein kurs zu sehen

Merger expected to be effective within a week The combined entity will be named Napo EU S.p.A. Merger effects the exclusive license agreement between Jaguar and Napo EU S.p.A. including up-front license fee due to Jaguar Napo EU S.p.A.'s initial focus is on the conditional marketing authorization pathway for orphan disease: short bowel syndrome with intestinal failure SAN FRANCISCO, CA / ACCESSWIRE / October 25, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the legally required "Golden Powers" process, enacted by the Italian government in response to the pandemic for pharmaceutical transactions with foreign participation, was successfully completed and that the merger of Jaguar's Italian subsidiary Napo EU S.p.A. and Dragon SPAC S.p.A. is expected to be effective within a week. "We are thrilled that the Italian government has granted Napo EU and Dragon SPAC clearance to proceed with the merger. As previously announced, the combined entity will have the exclusive license agreement with Jaguar to the crofelemer pipeline in Europe, which includes requirements for typical up-front license fees, milestone payments, royalties, and a drug supply agreement. Jaguar also maintains a meaningful majority equity interest in the combined entity, which will retain the name Napo EU S.p.A.," stated Lisa Conte, Jaguar's president and CEO and Napo EU board member. "Looking further ahead, we would expect to seek a public listing for Napo EU on a European exchange."